華潤置地(01109.HK):「華夏基金華潤有巢REIT」今於上交所正式上市
華潤置地(01109.HK)宣布,華夏基金華潤有巢租賃住房封閉式基礎設施證券投資 基金(REIT)於2022年10月30日獲中證監出具的準予註冊批覆。
該REIT今日(9日)起於上海證券交易所上市,交易代碼為(508077.SH),其場內短簡 稱為「華潤有巢」,場內擴位簡稱為「華夏基金華潤有巢REIT」,場外簡稱則為「華夏基金華潤有巢REIT」。
集團表示,REIT募集基金份額5億份,最終發售價格為每份2.417元人幣。根據最終發售價格,建議上市所得款項總額逾12.08元人幣。
公司表示,已認購1.7億份,佔已發行基金份額總數34%,緊隨建議分拆完成後,該等項目公司不再為公司的附屬公司,該等項目公司的賬目亦不再併入公司的賬目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.